ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
Dow Jones
38.675,68
1,18%
Euro vs US Dollar
1,07735
0,00%
Bitcoin
62.837,52
-0,08%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Bio Techne Corporation (TECH)

  7. Bio Techne Corporation (TECH) News

TECH Bio Techne Corporation

77,29
1,69 (2,24%)
03 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Bio Techne Corporation TECH NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
1,69 2,24% 77,29 22:28:53
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
76,89 76,18 77,98 77,29 75,60
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202412:30PRNUSBIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
30.4.202413:00PRNUSBIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF..
29.4.202413:00PRNUSBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO..
26.4.202413:00PRNUSBIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR..
23.4.202413:00PRNUSBIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST..
10.4.202413:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO..
08.4.202413:00PRNUSBIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS..
03.4.202413:00PRNUSBIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR..
01.4.202413:00PRNUSBIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR..
28.3.202414:00PRNUSBIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP..
22.3.202412:00PRNUSBIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR..
12.3.202412:00PRNUSBIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH..
11.3.202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202421:03EDGAR2Form 144 - Report of proposed sale of securities
06.3.202413:00PRNUSBIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL..
07.2.202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.2.202400:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.2.202400:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
06.2.202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202412:30PRNUSBIO-TECHNE RELEASES SECOND QUARTER FISCAL 2024 RESULTS
29.1.202413:00PRNUSBIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW..
25.1.202413:00PRNUSLUNAPHORE AND ACD REVOLUTIONIZE SPATIAL BIOLOGY RESEARCH..
24.1.202413:00PRNUSSCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN..
16.1.202413:00PRNUSBIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2024, TO..
08.1.202412:32EDGAR2Form 8-K - Current report
05.1.202413:00PRNUSBIO-TECHNE ANNOUNCES APPOINTMENT OF MATTHEW F. McMANUS AS..
04.1.202413:00PRNUSBIO-TECHNE TO SHOWCASE CELL AND GENE THERAPY MANUFACTURING..
21.12.202322:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.12.202313:00PRNUSBIO-TECHNE TO PRESENT AT THE 42nd ANNUAL J.P. MORGAN..
20.12.202313:00PRNUSBIO-TECHNE ANNOUNCES SUBMISSION OF FDA DRUG MASTER FILE FOR..
15.12.202300:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
14.12.202313:00PRNUSLUNAPHORE AND SIB AWARDED INNOSUISSE FUNDING TO DEVELOP..
27.11.202313:00PRNUSBIO-TECHNE TO PRESENT AT THE 6TH ANNUAL EVERCORE ISI..
13.11.202313:00PRNUSBIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES
07.11.202322:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.11.202312:00PRNUSASURAGEN TO PRESENT NOVEL CLINICAL TESTING DATA AT AMP 2023..
31.10.202311:30EDGAR2Form 8-K - Current report
31.10.202311:30PRNUSBIO-TECHNE RELEASES FIRST QUARTER FISCAL 2024 RESULTS
30.10.202321:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.10.202321:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
TECH
Bio Techne
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten